Activity Overview

This educational activity is an archive of the live conference held on January 24, 2026.

Target Audience

This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in lung cancer. Other health care professionals interested in the treatment of lung cancer are also invited to participate.

Learning Objectives

Implement the latest evidence-based, guideline-preferred approaches to biomarker testing for determining treatment plans for patients with lung cancer
Integrate emerging clinical trial evidence regarding the management of patients with lung cancer into personalized treatment plans

Leah M. Backhus, MD, MPH, FACS

Thelma and Henry Doelger Professor of Cardiovascular Surgery
Stanford University
Palo Alto, CA

Wally Curran, MD, FACR, FASCO

Whitaker Endowed Chief of Piedmont Oncology
Professor Emeritus and Lawrence D. Davis Chair Emeritus of Radiation Oncology
Georgia Research Alliance Eminent Scholar and Chair Emeritus in Cancer Research
Winship Cancer Institute of Emory University
Atlanta, GA

Corey J. Langer, MD, FACP

Professor of Medicine
Director, Thoracic Oncology
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA

Lani Park, PhD, MPH

Professor
Program Co-Leader, Population Sciences in the Pacific Program
University of Hawai‘i Cancer Center
Honolulu, HI

Michael Roach, MD

Radiation Oncologist
Cancer Center of Hawaii
Honolulu, HI

Ayman Abdul-Ghani, MD

Clinical Assistant Professor
John A. Burns School of Medicine
University of Hawaiʻi at Mānoa
Cardiothoracic Surgeon
Hawai‘i Pacific Health
Honolulu, HI

Anne Chiang, MD, PhD

Associate Professor, Section of Thoracic Oncology
Yale School of Medicine
Associate Cancer Center Director, Clinical Initiatives
Yale Cancer Center
New Haven, CT

Eric Crawley, MD

Pulmonologist
Hawai‘i Pacific Health
Honolulu, HI

Sarah Goldberg, MD, MPH

Professor of Internal Medicine
Co-Director, Center for Thoracic Cancers
Chief, Thoracic Oncology
Yale School of Medicine
New Haven, CT

Taryne A. Imai, MD, MEHP, FACS

Director, Thoracic Surgery
The Queen’s Health Systems
Honolulu, HI

William Loui, MD, FACP

Medical Oncologist
Adventist Health Castle
Kailua, HI

Mark D. Mayeda, MD

Radiation Oncologist
The Queen’s Health Systems
Honolulu, HI

Brian L. Pettiford, MD, MBA, MMM, FACS

Section Head, General Thoracic Surgery
Division of Cardiothoracic Surgery
Department of Surgery
Ochsner Medical Center
New Orleans, LA

Christina Speirs, MD, PhD

Radiation Oncologist
Cancer Center of Hawaii
Pacific Radiation Oncology
Honolulu, HI

Nicholas Stollenwerk, MD

Health Sciences Clinical Professor, UC Davis Health
Pulmonary and Critical Care Medicine
Interventional Pulmonology
UC Davis Comprehensive Cancer Center
Sacramento, CA

Nicolas Villanueva, MD

Assistant Clinical Professor
Department of Medicine
John A. Burns School of Medicine
University of Hawaiʻi at Mānoa
Clinical Faculty
University of Hawai‘i Cancer Center
Hematology/Oncology
Hawaii Oncology, Inc
Honolulu, HI

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.25 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Inc; Daiichi Sankyo, Inc; and Merck Sharp & Dohme, LLC.

Module 1: Stage I-III NSCLC